By continuing to use the site, you agree to our use of cookies and to abide by our Terms and Conditions. We in turn value your personal details in accordance with our Privacy Policy.
Please log in or register. Registered visitors get fewer ads.
Antibody-oligonucleotide conjugates (AOCs) are a novel class of synthetic chimeric biomolecules that has been continually gaining traction in different fields of modern biotechnology. Creative Biolabs focuses on developing this new class of oligonucleotide conjugates to overcome the current limitations of oligonucleotide (ON) therapies for a wide range of serious diseases.